Our GLP general toxicology team conducts GLP general toxicology studies in full compliance with CFDA, FDA, OECD or ICH regulations. The team has 15 study directors, of which 7 have over 13 years' of experience in pre-clinic drug development.The team is good at finding, analyzing and solving drug development problems innovatively. The team offer valuable expertise in standard or customized study protocol design to our clients based on nature of the substances and specific regulatory needs of clients.

Since 2002, our general toxicology team has accomplished over thousand of studies for over 300 new drugs. They are well experienced in a wide range of administration routes, including nasal feeding, nasal cavity, rectum, urethra, vagina,implant and micro-pump continuous infusion at constant speed, in rodent and non-rodent species.

• Dose Finding Studies (Rodent and Non-rodent)
•  Single Dose / Acute Toxicity (Rodent and Non-rodent)
• Repeat Dose / Sub-chronic and Chronic (Rodent and Non-rodent)

• Formulation Safety Studies (Irritation, Sensitization and Hemolysis)